Showing results (91-100 of 140) with videos related to
Sort By:
Pageof 14
Clinical Transplantation|July 13, 2005
Case of emphysematous pyelonephritis in a renal allograftShiro Fujita, Jota Watanabe, Alan I Reed, et al.Pediatric Transplantation|November 27, 2008
Hepatocellular carcinoma in a 10-month-old biliary atresia childTaku Iida, Ivan R Zendejas, Liise K Kayler, et al.Surgical Infections|July 24, 2010
Bacillus cereus necrotizing fasciitis in a patient with end-stage liver diseaseAndrea Hutchens, Asmita Gupte, Priscilla F McAuliffe, et al.Annals of Surgery|May 2, 2003
Preoperative portal vein embolization for extended hepatectomyAlan W Hemming, Alan I Reed, Richard J Howard, et al.Cancer Chemotherapy and Pharmacology|October 22, 2013
A phase II study of pemetrexed in patients with previously heavily treated non-squamous non-small cell lung cancer (HANSHIN Oncology Group 001)Yoshihiro Hattori, Miyako Satouchi, Nobuyuki Katakami, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 22, 2012
[Cisplatin administration for outpatients with short hydration of less than four hours]Akito Hata, Nobuyuki Katakami, Yoshio Masuda, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 16, 2011
[Direct low-dose fentanyl patch (2.1mg) introduction for opioid naïve outpatients with cancer pain]Akito Hata, Nobuyuki Katakami, Yoshio Masuda, et al.Transplantation|January 1, 2008
Is early recurrence of hepatitis C associated with biliary anastomotic stricture after liver transplantation?Shiro Fujita, Takahisa Fujikawa, Shugo Mizuno, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 19, 2010
Cerebrospinal fluid concentration of erlotinib and its active metabolite OSI-420 in patients with central nervous system metastases of non-small cell lung cancerYosuke Togashi, Katsuhiro Masago, Masahide Fukudo, et al.Japanese Journal of Clinical Oncology|October 31, 2013
A phase II study of pemetrexed in chemotherapy-naive elderly patients aged ≥ 75 years with advanced non-squamous non-small-cell lung cancer (HANSHIN Oncology Group 003)Yoshihiro Hattori, Masahiro Iwasaku, Miyako Satouchi, et al.Pageof 14